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Abstract. The characterization of a novel 59-kD cy- 
toskeletal protein is described. It is exclusively ob- 
served in smooth muscle cells by Northern blotting and 
immunohistochemical analysis and therefore desig- 
nated "smoothelin." A  human smooth muscle cDNA 
library was screened with the monoclonal antibody 
R4A, and a full-size cDNA of the protein was selected. 
The cDNA was sequenced and appeared to contain a 
1,113-bp open reading frame. Based on the cDNA se- 
quence, the calculated molecular weight of the 
polypeptide was 40 kD and it was demonstrated to con- 
tain two N-glycosylation sites. Computer assisted analy- 
sis at the protein level revealed a 56-amino acid do- 
main with homologies of ~40% with a sequence 
bordering the actin-binding domains of dystrophin, 
utrophin, [3-spectrin and a-actinin. In situ hybridization 
demonstrated that human smoothelin is encoded by a 
single copy gene which is located on chromosome 22. 
Immunohistochemistry and Western blotting revealed 
synthesis of smoothelin in smooth muscle of species 
evolutionarily as far apart as human and teleost. North- 
ern blotting indicated that sequence as well as size of 
the mRNA (~1,500 bases) are conserved among verte- 
brates. Cell fractionation studies and differential cen- 
trifugation showed that the protein cannot be extracted 
with Triton X-100, which indicates that it is a part of the 
cytoskeleton. Transfection of the human cDNA into 
smooth muscle cells and COS7 cells produced a protein 
of 59 kD, which assembled into a filamentous network. 
However, in rat heart-derived myoblasts association 
with stress fibers was most prominent. Smoothelin was 
not detected in primary or long term smooth muscle 
cell cultures. Also, transcription of smoothelin mRNA 
was almost instantly halted in smooth muscle tissue ex- 
plants. We conclude that smoothelin is a new cytoskele- 
tal protein that is only found in contractile smooth mus- 
cle cells and does not belong to one of the classes of 
structural proteins presently known. 
S 
MOOXH muscle cells are of mesodermal origin and are 
present in the wall of almost the entire gastrointesti- 
nal tract, essential parts of the cardiovascular sys- 
tem, the respiratory, system, the urinary tract, and in the 
reproductive system. Differences in size, function, and bio- 
chemistry between smooth muscle cells in different organs 
have been observed and may reflect differences in origin 
and state  of differentiation (Gabbiani et al.,  1981;  Hae- 
berle et al., 1992; Owens, 1995). 
Smooth muscle  cells  can  be  divided into  two  pheno- 
types: a  proliferative (synthetic) and a contractile pheno- 
type. Proliferative smooth muscle cells can differentiate to 
the contractile phenotype. The differentiation process is, 
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contrary to that in striated muscle cells, reversible, a phe- 
nomenon referred to as modulation. As deduced from em- 
bryological studies, smooth muscle differentiation is char- 
acterized by the onset of expression of a particular set of 
proteins, some of which are characteristic for the different 
phenotypes  (Campbell  and  Chamley-Campbell,  1981; 
Skalli et al., 1986; Campbell et al., 1989; Owens, 1995). For 
the understanding of smooth muscle differentiation, it is 
important to distinguish proteins that are characteristic for 
a given stage of smooth muscle differentiation. 
Contractile,  cytoskeletal,  and  cytoskeleton-associated 
proteins have been described as  differentiation markers 
for smooth muscle cells but their value as such is not well 
defined (Takahashi et al.,  1988; Gunning et al., 1990; Ba- 
bai et al.,  1990; Nanaev et al., 1991; Duband et al., 1993; 
Owens, 1995). At present, marker proteins such as smooth 
muscle  myosin,  a-smooth  muscle  actin,  (meta)vinculin, 
SM22,  calponin, and  h-caldesmon, are considered to be 
smooth muscle specific and some have been suggested to 
be phenotype-specific (Glukhova et al.,  1986; Lees-Miller 
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et al., 1992). However, they do occasionally occur in other 
cell types, a-Smooth muscle actin expression is also found 
in developing striated muscle cells and in pathologic car- 
diac  muscle  (Babai  et  al.,  1990;  McHugh  et  al.,  1991; 
Ausma  et al.,  1995).  Marker proteins, such  as calponin, 
metavinculin,  and  isoforms  of  myosin,  have  also  been 
found in pericytes, platelets, and endothelial cells (Turner 
and  Burridge,  1989;  Nagai  et  al.,  1989;  Borrione et  al., 
1990;  Takeuchi  et  al.,  1991).  Taken  together  it  can  be 
stated that expression of most of these marker proteins is 
observed in rather early, i.e., proliferative stages of differ- 
entiation  and  so far only smooth muscle  myosin heavy 
chain isoforms may function as markers for the contractile 
phenotype of smooth muscle (Owens, 1995). 
Here we describe the cloning of a cDNA coding for a 
smooth muscle-specific protein, which has been character- 
ized and designated smoothelin. The protein is expressed 
in  cells  of smooth  muscle  tissues  investigated, but  only 
when these cells are fully differentiated and are part of 
contractile  tissue.  Smoothelin  forms  a  filamentous  net- 
work, if transfected into  COS7  or smooth muscle cells. 
However, it does not belong to one of the known families 
of structural  proteins.  It may be  a  valuable  addition  to 
markers used for the assessment of the state of differentia- 
tion of smooth muscle cells. 
Materials and Methods 
Tissue Samples and Cell Culture 
Normal adult human tissues, obtained at autopsy, and tissues from a vari- 
ety of animals (pig, dog, cattle, rabbit, rat, mouse, the toad Xenopus laevis, 
and the fish Oreochromus  mossambicus)  were immediately frozen in liq- 
uid nitrogen and stored at -80°C until use. Smooth muscle cells were ob- 
tained from human vena, bovine aorta, embryonic chicken gizzard, human 
uterine, and mammary artery by enzymatic dispersion (collagenase/pan- 
creatin: Life Technologies, Gaithersburg, MD). Embryonic chicken giz- 
zard cells were cultured for 72 h at high density on gelatin-coated cover- 
slips.  Smooth  muscle  cells  cultured  for  at  least  five  passages  are 
considered to be "long-term cultures." The rat heart-derived myoblast cell 
line H9C2(2-1)  (Kimes and  Brandt,  1976)  and  COS7  cells (Gluzman, 
1981)  were purchased from Amer. Type Culture Collection (Rockville, 
MD). Cells were cultured in Dulbecco's Modified Essential Medium sup- 
plemented with 15% FCS (Life Technologies). For the myoma tissue ex- 
plants 1-mm thick tissue slices were incubated as described for the cell cul- 
tuFes. 
For immunohistochemistry tissues were mounted in Tissue-Tek (OCT- 
compound; Miles Inc. Elkhart, IN), and 3-5-1~m thick sections were cut at 
-25°C and air-dried overnight at room temperature or immediately fixed 
with methanol (at -20°C for 5 min) followed by acetone (-20°C for 30 s) 
and air-dried for 3 h before use. Cells were grown on coverslips and also 
fixed in methanol/acetone. 
Antibodies 
Antibodies used in this study were (1) the mouse monoclonal antibody 
R4A directed against smoothelin. To generate the antibody mice were im- 
munized with the residue of a chicken gizzard preparation, extracted with 
high salt/Triton X-100.  Fusion procedure and cloning of the hybridomas 
were performed according to standard protocols (Krhler and Milstein, 
1975). The monoclonal antibody R4A was selected on the basis of its spe- 
cific reactivity pattern with a  selection of human cardiac, skeletal, and 
smooth muscle tissues. R4A is an antibody of the IgGl-subclass (Mouse 
mAb Isotyping kit; Life Technologies); (2) monoclonal antibody E7 to 
[3-tubulin  (Chu et al.,  1987);  (3) polyclonal rabbit antiserum (pDes) to 
chicken  gizzard  desmin  (Ramaekers  et  al.,  1985);  (4)  affinity-purified 
polyclonal rabbit antibodies (pVim) raised against bovine lens vimentin 
(Ramaekers  et  al.,  1983);  (5)  monoclonal antibody RD301  to  desmin 
(Schaart  et  al.,  1991);  (6)  affinity-purified polyclonal rabbit antibodies 
(pKer) raised against human skin keratins (Ramaekers et al., 1983); and 
(7) monoclonal antibody sm-1 to smooth muscle actin was purchased from 
Sigma ImmunoChemicals (St. Louis, MO) (Skalli et al., 1986). 
In addition, rhodamine-labeled phalloidin (purchased from Molecular 
Probes Inc., Eugene, OR) was used to stain actin stress-fibers. 
Immunohistochemistry 
For the characterization of antibody R4A, immunofluorescence as well as 
immunoperoxidase staining has been performed on a variety of tissues of 
different species. In all cases 3-5-1xm-thick  cryostat sections were used. 
The sections were pretreated for 5 min with 0.5% Triton X-100 (BDH 
Chemicals Ltd., Poole, UK) in PBS (137 mM NaC1,13 mM NazHPO4.2H20, 
3 mM KH2PO4, pH 7.4; Merck, Darmstadt, Germany), followed by a PBS 
washing step for 5 min. Methanol/acetone fixed sections were used with- 
out Triton X-100 pretreatment. 
Tissue sections or fixed cells were incubated with the primary antibody 
for 30 min at room temperature, washed with PBS, and incubated with a 
secondary  antibody  conjugated  to  either  fluorescein  isothiocyanate 
(FITC) (goat anti-mouse-IgG-FlTC, Southern Biotechnology Associates 
Inc., Birmingham, AL), or Texas red (TR) (goat anti-rabbit-Ig-TR/goat 
anti-mouse-IgG1-TR; SBA), or horseradish peroxidase (peroxidase-con- 
jugated  rabbit anti-mouse; DAKO  A/S,  Copenhagen, Denmark).  The 
secondary antibodies-were applied for 30 min at room temperature. Per- 
oxidase activity was detected with 4-amino-9-ethylcarbazole (AEC; Al- 
drich  Chemical  Company,  St.  Louis,  MO)  as  described  previously 
(Schaart et al.,  1991).  After three washing steps with PBS, the fluores- 
cently stained tissues were mounted in Mowiol (HOECHST, Frankfurt, 
FRG) or in Kaiser's glycerin-gelatin (Merck) for AEC-stained sections. 
Protein Gel Electrophoresis and Western blotting 
Cultured cells (~106) or about 40 cryostat sections (each 20-p,m thick) of 
fresh frozen tissues were collected, washed with 1 ml PBS, and centrifuged 
for 5 min at 12,000 g.  After centrifugatton, the pellet was subjected to a 
Triton X-100 extraction step and after a PBS wash suspended in 1% Tri- 
ton X-100, 5 mM ethylenediaminotetraacetic acid disodium salt dihydrate 
(EDTA; Merck), 0.4 mM phenylmethylsulfonyl fluoride (PMSF; Merck) 
in PBS, pH 7.4 (Schaart et al., 1991), and extracted for 5 min on ice. After 
centrifugation for 5 min at 12,000 g, the pellet was washed in 1 ml PBS. 
After a final centrifugation step (5 min, 12,000 g), the cytoskeletal prepa- 
ration was dissolved by  boiling for 4  min in  sample buffer (Laemmli, 
1970), containing 2.3 % sodium dodecylsulfate (SDS) and 5 % [3-mercapto- 
ethanol (BioRad Laboratories, Richmond, CA). Removal of N-glycosyla- 
tion residues was achieved by treatment of smooth muscle homogenates 
by neuramidase (50 U/ml) (Sigma) in the presence of leupeptin (1 p,g/ml) 
and PMSF (20 raM) for 5 h at 37°C under conditions as advised by the 
manufacturer. 
For  one-dimensional SDS-PAGE  using a  Mini  Protean  II  Electro- 
phoresis Cell (Bio-Rad Laboratories) 7.5-10% polyacrylamide slab gels 
containing 0.1% SDS (Laemmli, 1970) were used. Two-dimensional non- 
equilibrium gel electrophoresis (pH gradient 3.5-10) was performed ac- 
cording to O'Farrell (1975). After electrophoretic separation, the proteins 
were stained with Page Blue 83 (BDH Chemicals Ltd.) or subjected to 
Western blotting as described elsewhere (Schaart et al., 1991). Culture su- 
pernatant of monoclonal antibody R4A directed against smoothelin was 
used in a 1:5 dilution and immunodetection with horseradish peroxidase- 
conjugated rabbit anti-mouse-Ig (DAKO A/S) was performed according 
to standard procedures (Schaart et al., 1991). 
Fractionation of Smooth Muscle Tissues 
by Differential Centrifugation 
All steps of the procedure described below were performed on ice and for 
centrifugation a T-60 rotor was used (Beckman Instrs., Fullerton, CA). 
Frozen tissue blocks of intestinal smooth muscle tissue (5 g wet weight hu- 
man colon) were minced and homogenized in 15-ml SET buffer (8.5% su- 
crose, 5 mM Tris-HC1,  pH 7.4, 2 mM EDTA) by a motor driven serrated 
teflon pestle at 1,000 rpm. (Braun Potter-S). Homogenates were passed 
through SET-soaked cheesecloth and pelleted at 1,000 g. Superuatants of 
the subsequent steps were centrifuged at 9,000, 20,000, and 110,000 g for 10, 
15, and 60 min, respectively. Samples of the pellets (resuspended in SET 
buffer without EDTA)  and the supernatants of different fractions were 
subjected to SDS-PAGE followed by Western blotting, as described above. 
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Muscle cDNA Expression  Library 
A  cDNA expression library was constructed with human colon smooth 
muscle derived poly-A÷RNA using the Lambda ZAP-cDNA synthesis kit 
(Stratagene, La Jolla, CA). Total RNA was extracted from human colon 
smooth muscle by LiC1 extraction (Auffray and  Rougeon,  1980).  Poly 
A+RNA was purified by oligo(dT)-cellulose chromatography (Aviv and 
Leder, 1972).  Synthesis of cDNA (by oligo(dT) priming) and packaging 
were performed as suggested by the manufacturer. After packaging the 
Uni-ZAP XR  vector in  phage  (Gigapack  II  Packaging  extract,  Strat- 
agene), clones containing cDNA inserts between 600 and 1,600 bp were 
selected by immunoscreening with antibody R4A. Inserts were subcloned 
and subjected to restriction analysis and sequencing after helper phage in- 
duced excision of plasmid vector pBluescript II pKS(-) (Stratagene). Se- 
quencing was performed according to Sanger et al. (1975)  using a T7 se- 
quencing  kit  (Pharmacia,  Uppsala,  Sweden).  Searches  for  sequence 
homology were performed through the CAOS/EMBL data base (release 
1995).  Sequence comparison and structural analysis of the putative pro- 
tein were performed on a UNIX computer using BLAST, BLAST-X algo- 
rithms (Altschul et al.,  1990), and protein structure program PHD (Rost 
and Sander, 1993,1994). 
To check whether the 1,554-bp  clone contained a full-size cDNA, total 
RNA of human colon smooth muscle tissue was subjected to rapid ampli- 
fication of cDNA ends (RACE)  (5'RACE-kit, Life Technologies). The 
RACE products were amplified using Pwo polymerase (Boehringer Mann- 
heim, Germany), cloned into pUC19 and sequenced as described above. 
Northern Blot Analysis 
Total RNA of various tissues and from a variety of vertebrates (human, 
bovine, dog, rat, and mouse) was extracted by LiC1 as described previ- 
ously (Auffray and Rougeon, 1980). 10 I~g of total RNA was separated on 
a 2% agarose formaldehyde denaturing gel (Sambrook et al., 1989). RNA 
was transferred to nitrocellulose (S&S, Basel, Switzerland) and hybridized 
to  the  smoothelin-cDNA  probe  according  to  standard  procedures 
(Church and Gilbert, 1984). Filters were washed in decreasing SSC (NaCI, 
Na-citrate) concentrations with a  final concentration of 0.1x  SSC/0.1% 
SDS. Probes were 32p-labeled by random priming using a kit with a DNA 
polymerase Klenow fragment (Life Technologies) according to Feinberg 
and Vogelstein (1983). 
Transfection  of Smoothelin cDNA into COS7 Cells 
The full-size smoothelin cDNA was recloned in a pcDNA3 eukaryotic ex- 
pression vector (Invitrogen, San Diego, CA) (this construct is further re- 
ferred to as pcDNA3-SMO).  Isolated plasmid was purified by CsCl gradi- 
ent centrifugation (Sambrook et al., 1989). Transfection of exponentially 
growing human primary smooth muscle cells, HGC2(2-1)  rat myoblasts, 
and COS7 cells was done with 5 Ixg purified DNA per 106 cells, using the 
DOTAP lipocarrier system as suggested by the manufacturer (Boehringer 
Mannheim, Germany). About 16 and 40 h  after transfection cells were 
fixed with methanol/acetone or harvested after trypsinization. Fixed cells 
were  incubated with  rhodamine-labeled phatloidine and  antibodies di- 
rected against smoothelin, vimentin, keratin,  and  tubulin  as  described 
above. Cells harvested after trypsinization were collected by centrifuga- 
tion and prepared for Western blotting analysis as described above. 
Production  of Smoothelin Protein in E. coli 
The smoothelin cDNA (1,593  bp clone) was excised from Bluescript II 
and  inserted into  the prokaryote expression vectors pQE9/10/ll  (Qui- 
agen, Kassel, Germany). Insertion in these vectors results in a fusion of 
the cDNA encoded protein to a 6-His peptide, allowing a single-step puri- 
fication of the protein by binding to Ni-agarose. Protein was synthesized 
during overnight induction with 1 p.M IPTG (Life Technologies). Proteins 
produced in E.coli were obtained by guanidine/urea extraction and puri- 
fied according to the protocol of the manufacturer (Quiagen). After sepa- 
ration by SDS-PAGE, proteins were blotted onto nitrocellulose and iden- 
tified by antibody R4A as described above. 
In Situ Hybridization 
Double target in situ hybridization on human metaphase preparations was 
performed as  previously described (Voorter  et  al.,  1995)  combining a 
digoxigenin-labeled chromosome 22 centromeric probe with the biotin- 
labeled  smoothelin cDNA  probe.  The  applied  concentration  of  both 
probes was  10  ng/~l  hybridization mix.  Hybridization  and  subsequent 
washes were performed according to standard procedures. The biotiny- 
lated probe was detected by FITC-conjugated avidin, and the digoxigenin- 
labeled probe by tetramethyl rhodamine isothiocyanate (TRITC), using 
an  anti-digoxigenin monoclonal antibody in combination with TRITC- 
conjugated rabbit anti-mouse and swine anti-rabbit sera (DAKO A/S). 
Results 
Generation and Characterization  of  Antibody R4A 
Balb/C mice were immunized with a  chicken gizzard ex- 
tract  and  hybridomas were  produced.  Antibody produc- 
tion was screened by immunofluorescence assays and by 
Western blotting on a  variety of tissues.  In immunofluo- 
rescence  assays on sections of several tissues hybridoma 
clone R4A, producing an IgG1 type antibody, reacted ex- 
clusively with  smooth  muscle  cells.  Western  blotting  of 
one- and two-dimensional gels confirmed the microscopi- 
cal observations. The immunoreactive protein was found 
to have an apparent molecular mass of 59 kD, migrated 
slightly slower than  desmin  (Fig.  1),  and,  as observed in 
two-dimensional gel electrophoresis,  appeared  to have a 
slightly  basic pI between  8.0  and  8.5.  Because  of its  re- 
stricted tissue distribution the 59-kD protein has been des- 
ignated "smoothelin." 
Molecular Cloning and Characterization  of Smoothelin 
A  cDNA library was constructed from poly(A)+RNA iso- 
lated from human colon smooth muscle tissue. This library 
was screened with the monoclonal antibody R4A. Of the 
25,000 plaques plated 14 were immunoreactive with R4A. 
The  size  of the  cDNA  inserts  varied  between  600  and 
1,550  bp, indicating that the epitope of R4A is located at 
least 150 amino acid residues away from the carboxy ter- 
minus (the last 150 bp are noncoding; Fig. 2 A). All clones 
Figure 1.  Western blot showing the immunoreaction of a  human 
colon smooth muscle preparation after subsequent incubations of 
the  same  blot  with  monoclonal  antibodies  R4A  (lane  b),  anti- 
desmin RD301  (lane c), and anti-smooth muscle actin sm-1 (lane 
d).  Lane  a  shows  the  Coomassie  Brilliant  blue  staining  of the 
preparation. Marker lane is indicated by M. Asterisk indicates a 
degradation product of actin. 
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5•GGCAcGAGCccGcTGCCcGTGGCCGTCGcACTGcCGAGCCAGGGGGcAGTATGAAGACCACATTCACCATCGAGATCAAG  80 
GACGGCCGTGGcAGGcCTcCACAGGcCGGGTGCTGCTGCcCACAGGCAACcAGAGGGcAGAACTGACACTGGGGCTGcGG  160 
GCGCcccGAcCCTAcTCAGCACcAGTAGTGGGGCAAGAGcACcATcACCCGTGTcAACAGCcCTGGGAcCcTGGCTCGGC  240 
met  glu  2 
TGGGCAGTGTCACTCATGTCACCAGCTTCAGCCATGCCCCCCCCAGTAGCCGAGGAGGCTGCAGCATCAAG  ATG GAA  317 
pro  glu  pro  ala  glu  pro  leu  ala  ala  ala  val  glu  ala  ala  ash  gly  ala  glu  arg  ala  22 
CCA GAG  CCA GCA GAG  CCT  CTC  GCT GCA GCA GTG GAA GCG GCC AAT  GGG  GCT  GAG  CGA GCC  377 
arg val  ash  lye  ala  pro  glu  gly  arg  arg  leu  ear  ala  glu  glu  leu met  thr  ile glu  42 
CGA GTG  AAC AAA GCA  CCA GAA GGG  CGG  CGT  CTG AGC GCT  GAG  GAG  CTG  ATG ACT  ATT  GAG  437 
asp glu  gly  val  leu  asp  lye met  leu  asp  gln  eer  thr  asp  phe  glu  glu  arg  lya  leu  62 
GAT  GAA GGA GTC  TTG  GAC  AAG ATG CTG  GAT  CAG  AGC  ACG  GAC 
ile  arg  ala  asp phe  val  SeE  ser  asp  lys  gly  arg  glu  thr 
AT___CCCGG GCT GAC  TTC GTG  AGe  TCN GACAAAGGA  AGA GAG  ACC 
asn gly  gly  cys  arg  arg  his  gly  ala  gly  gln  gly  arg  gly 
AAC GGC GGC TGC  AGG  AGG  CAC  GGG  GCC  GGC  CAG  GGG  AGG  GGC 
arg pro  pro  arg  gly  thr  ala  ala  gly  set  asp  gly  ser  ala 
AGA CCA  CCA  CGA GGC  ACA GCA GCG  GGC  AGC GAT  GGC  TCT GCT 
thr glu  arg  leu  val  hie  set  ash  asp  gly  thr  arg  thr  ala 
ACT GAG CGG  CTC GTC  CAC  TCC AAT GAT GGC ACA CGG ACG GCC 
set  eer  phe  val  arg  arg  SeE  glu  asn  gly  eer  gly  get  thr 
TCG AGT  TTC GTG  AGG  CGC  TCG GAG  AAT  GGC  AGT  GGC AGC  ACC 
phe  ser  set  ser  set  aer  SeE  lys  lye  met  gly  ser  ile phe 
TTC  TCC  TCT  TCC  TCC  TeA TCC AAG  AAG ATG  GGC  AGe  ATe  TTC 
ale thr  gly  arg  his  gly  arg  leu glu  set glu  lys  arg  gln 
GCC ACG GGC  CGC  CAT GGC  CGG  CTC GAG  AGT  GAG AAA CGG  CAG 
leu met  lye  ala  gln  ser  leu  pro  lys  thr  ser  ala  set  gln 
CTG ATG AAG  GCG CAG AG  T  CTG  ccc A~G  ACC  TCA GC9  TCC  CAG 
glu  lye  leu glu  lye  glu  gly  ala  ale  gly  ser  pro  ala  asp 
GAG AAG  CTG GAG  AAG GAG GGC GCG GCC GGC AGC  CCT  GCG  GAC 
asp  pro  pro  ala  set  gly  ser  pro  thr  pro  thr  ala  ser  set 
GAT  CCA CCA  GCT  TCG  GGG  TCC  CCA ACG  CCA ACA GCA  TCA  AGC 
glu  pro  arg  leu  gly  alaJtyr  glu  his  val  asp  ile gln  val 
GTC GAG  CCA AGA CTC  GGG  GCCJTAC  GAG  CAC GTC GAC  ATC  CAG 
set  asp gly met  ala  phe  cye  ala  leu  val  hie  ash  phe  phe 
AGT  GAT GGG ATG  GCC  TTC  TGT  GCC  CT  G  GTG  CAC AAC  TTC  TTC 
gly  gln  leu  ser  pro  gln  asn  arg  arg  gln  ash  phe  glu  val 
GGG  CAG  CTT AGC  CCT  CAG  AAC  CGA  CGC  CAG AAC  TTC  GAG  GTG 
met  leu  val  asp tyr  val  pro  leu  val  glu  val  asp  asp met 
ATG  CTG GTG GAC  TAT  GTG  CCC  CTG GTG  GAG  GTG  GAC  GAC  ATG 
pro  asp pro  lye  cys  val  phe  thr  tyr  val  gln  ser  leu  tyr 
CCT GAC  CCC AAG  TGT  GTC  TTC ACC  TAT  GTG  CAG  TCG  CTC  TAC 
glu  leu  ala  set  arg  gly  lye  ash  val  ***  373 
GAA  CTG  GCC  TCG  CGC  GGC  AAG AAT  GTC  TAG  CCTGCCCGCCCGCATGGCCAGCCAGTGGCAACTGCCGCC  1466 
CCCACTCTCCGGGCACCGTCTCCTGCCTGTGCGTCCGCCCACCGCTGCCCTGTCTGTTGCGACACCCTCCCCCCCACAT  1545 
ACACACGCAGCGTTTTGATAAATTATTGGTTTTCAACG(A~  l  1593 
TTT  GAA GAG  eGG  AAG  CTC  497 
ser  gly  thr  arg  set  gly  82 
AGC  GGG ACA  AGG AGC  GGG  557 
ala  ala  thr  gln  pro  leu  102 
GCG  GCA ACA  CAG  CCA  CTG  617 
val  ser  thr  val  thr  lye  122 
GTC  AGC  ACT  GTT ACC AAG  677 
arg  thr  thr  thr  val  glu  142 
CGC  ACC  ACC  ACA GTG  GAG  737 
met  met  glu  thr  lye  thr  162 
ATG  ATG  CAA ACC AAG  ACC  797 
asp  arg  glu  asp  gln  arg  182 
GAC  CGC  GAG  GAC  CAG  CGA  857 
ala  glu  lye  lye  ly8  glu  202 
GCC GAG  AAG AAG  AAA GAG  917 
ala  arg  lye  ala met  ile  222 
GCG  CGC AAG GCC ATG ATT  977 
pro  ala  gln  pro  cys  aer  242 
CCC GCG  CAG  CCG  TGC  AGe  1037 
arg  set  set  trp  thr  gly  262 
AGA  TCG  TCG  TGG  ACT  GGT  1097 
ash  phe  ser  ser  ser  trp  282 
AAC  TTC  TCC  TCC AGC  TGG  1157 
pro  glu  ala  phe  asp tyr  302 
CCT GAG  GCC  TTC GAC  TAT  1217 
ala  phe  ear  ser  ala glu  322 
GCC  TTC  TCA TCT  GCG GAG  1277 
met  ile met  gly  lye  lye  342 
ATG  ATe  ATG  GGC AAG AAG  1337 
asn  his  leu  arg  arg  his  362 
AAC  CAC  CTG  CGA  CGC  CAC  1397 
B:  Amino  acid  homoloaies. 
protein  position  sequence  homology 
human  smoothelin  270  YEHVDZQNIr888WSDGMAFCALVHNFPPEAFDYGQLS-PQNP.RQNFEVAF88AEI4LV 
human  beta-spectrin  190  YPH~[NVTNTT88WKDGLA~NALIKKHRPDLIDFDKLK-DS~EHAFNVAERQL  46% 
human  alpha-actinin  180  YKNVNIQNFHISWKDGLGICALIHRHRPBLIDYGKLR-KDDPLTNLNTAFDVAEKYL  45% 
human utrophin  166  YSQVNVLmFTTSWTDGLAFNAVLHRHKPDLFSWDKVV-KMSPIERLEHAFSKAQTYL  34% 
human  dystrophin  151  MPQVNVINFTTSWSDGL~LNALIHSHRPDLFDWNSWCQQSATQRLEHAFNIARTQL  35% 
Figure 2.  (A) Nucleotide se- 
quence  of  the  smoothelin 
cDNA  selected  from  a  hu- 
man  colon  smooth  muscle 
cDNA  library  and  the  de- 
duced  amino  acid  sequence 
of the putative protein.  The 
sequence with homologies to 
members  of the spectrin  su- 
per-family is boxed. Potential 
helical  secondary  structures 
are underlined. The polyade- 
nylation signal is underlined. 
Notice the number of proline 
and  proline-alanine  residues 
in  the  area  preceding  the 
boxed  sequence.  (B)  Amino 
acid sequence of homologous 
regions  of  human  smoothe- 
lin, and members of the spec- 
trin  family,  human  13-spec- 
trin, human a-actinin, human 
utropin,  and  human  dystro- 
phin.  Homologies  are  indi- 
cated by bold letters. 
isolated  contained  sequences  similar  to  the  four  largest 
clones, as deduced from restriction patterns. The complete 
nucleotide  sequence  and  deduced  amino  acid  sequence 
are presented  in Fig.  2 A. To check whether the  largest 
clone contained a full-size cDNA, a 5'RACE reaction was 
performed. No additional sequence was found which indi- 
cated  that  the  1,593-bp  clone  contained  the  full-length 
cDNA.  The  1,593-bp  cDNA  contains  a  1,113-bp  open 
reading  frame  that  encodes  a  putative  protein  of  371 
amino  acids.  Other  open  reading  frames  were  much 
shorter. Smoothelin has a relatively high number of serine 
(11.5%), alanine (10%), arginine (8.4%), and methionine 
(3.5%)  residues.  The calculated molecular weight of the 
protein, as deduced from the largest open reading frame of 
smoothelin, is 40.406 kD with a pI of 8.5. 
Western blotting of smoothelin cDNA transfected COS7 
The Journal of Cell Biology, Volume 134, 1996  404 Figure  3.  R4A  immunostained  Western  blot  of human  colon 
smooth muscle extract (lane a), prokaryotic product based on the 
full-size cDNA in pQE9 (lane  b), COS7  cells transfected with 
pcDNA3-SMO (lane c), and COS7 cells transfected with pcDNA3 
(lane d). Lanes e and f are Coomassie Brilliant blue-stained pro- 
teins corresponding with lanes c and d, respectively. Lanes g and 
h show human smoothelin in colon tissue before and after a 5-h 
incubation  with neuramidase. Marker lane is indicated  by M. 
cells  revealed  a  59-kD,  R4A  reactive protein,  the  same 
size as the protein found in smooth muscle tissues such as 
colon (Fig. 3, lanes a  and c). Transcription and translation 
of the full-size cDNA of smoothelin in a prokaryotic expres- 
sion system gave an ,'-,60-kD, R4A immunoreactive mole- 
cule  (Fig.  3,  lane b). The calculated molecular weight of 
this product was ~50 kD because of the  added 6His-tag 
and the translation of the 5' noncoding cDNA region. Fur- 
ther analysis shows that the putative protein contains two 
Asn-X-Ser sequences (residues 151 and 277), which are re- 
quired  for  asparagine-linked  N-glycosylation  (Pless  and 
Lennarz,  1977).  Treatment  of  smooth  muscle-derived 
smoothelin with neuramidase resulted in a reduction of the 
molecular mass by ~-,10 kD (Fig. 3, lanes g and h). 
Sequence homology at the nucleic acid and protein level 
with  members  of  the  spectrin  superfamily,  dystrophin, 
utrophin,  13-spectrin,  and a-actinin was found for the re- 
gion between amino acid residues 270 and 331 of smoothe- 
lin  (Fig.  2  B).  Even  if conserved  mutations  are  not  in- 
cluded,  this region of smoothelin showed 39%  homology 
with  human  and  mouse dystrophin,  46%  homology with 
human and mouse 13-spectrin,  and 34% for human utropin. 
Homologies with a-actinin varied from 46% for human to 
26%  for D.  discoideum.  For the members of the spectrin 
family, this  region  is  located  directly following  the  sug- 
gested actin-binding site of these molecules. 
The secondary structure of the putative protein was ana- 
lyzed  by  PHD,  a  neural  network  program  (Rost  and 
Sander, 1993,  1994). Since no homologous sequences were 
available in the Swissprot databank, the expected accuracy 
of  this  method  was  estimated  between  62  and  66%. 
Smoothelin  has  two  regions  with  a  potential  helical  do- 
main: between amino acid residues 6 and 63, and between 
residues  179  and 229.  In addition,  in the region showing 
homology with the spectrin family proteins short stretches 
are found with helical potential (Fig. 2 A). However, even 
the rather large helical structures of smoothelin are con- 
siderably smaller than the ones found in, for instance, in- 
termediate  filament proteins.  Proline  residues  are found 
next to the first helical region and in a proline-rich stretch 
(>35%)  between residues 234 and 252 preceding the re- 
gion homologous to the spectrin family. 
In situ  hybridization with a  combination of a  chromo- 
some 22 centromeric probe and the 1,593-bp cDNA dem- 
onstrated that the gene coding for smoothelin is located on 
human chromosome 22 (Van der Loop, 1996). 
Expression of Smoothelin 
Northern blot analysis of RNA from several human tissues 
containing  smooth muscle cells,  such  as  colon,  stomach, 
uterus, and aorta showed a band of N1,500 bases after hy- 
bridization with the smoothelin cDNA probe (Fig. 4). No 
such  hybridization  signal  was  found  with  RNA  isolated 
from  brain,  adipose  tissue,  cardiac  and  skeletal  muscle, 
and  intestinal  epithelium  (Fig. 4).  Northern  blot analysis 
of RNA of smooth muscle containing tissues derived from 
different  species  such  as  mouse,  rat,  dog,  and  bovine 
showed a strong hybridization signal (under stringent hy- 
bridization conditions)  and revealed no visible difference 
in mRNA size between these species (Fig. 4). 
The results of the Northern blot analysis were in agree- 
ment with the immunohistochemical screening of a  num- 
ber of different human tissues such as stomach, uterus, co- 
lon,  prostate,  aorta,  and  other  arteries  with  monoclonal 
antibody  R4A.  Smooth  muscle  cells  in  all  these  tissues 
were positive whereas other tissue types, such as striated 
muscle,  myoepithelium,  myofibroblasts  in  Dupuytren's 
Figure 4.  Northern blot of a number of different tissues obtained from several species. Equal amounts of total RNA are applied to the 
gel. All RNAs hybridizing to the 32p-labeled smoothelin cDNA probe appear to be of the same size. RNAs were extracted from the fol- 
lowing tissues: mouse stomach (a), rat uterus (b), rat stomach (c), rat skeletal muscle (d), dog stomach smooth muscle (e), dog intestinal 
smooth muscle (f), dog intestinal  epithelium  (g), bovine small intestinal  smooth muscle (h), bovine skeletal muscle (i), bovine heart (/'), 
human small intestinal  smooth muscle (k), human uterus (1), and human intestinal epithelium  (m). 
van der Loop  et al. A Smooth Muscle Cell  Specific Cytoskeletal  Protein  405 Figure 5.  Immunohistochemical screening of different species and tissues for the presence of smoothelin. Intestinal smooth muscle tis- 
sue of human (a), goat (b), Xenopus laevis (d), and chicken oesophagus (c) were all positive for R4A. In human large intestine (e), stom- 
ach (]), uterus (g), and prostate (h), smooth muscle cells showed a strong reaction with R4A (f and h show peroxidase staining). In rab- 
bit (k) and cat (/) heart tissue only smooth muscle cells surrounding the blood vessels are visualized by R4A, Double-stained sections of 
human heart (i and j), chicken skeletal muscle (m and n) and human breast myoepithelial cells (o and p) incubated with R4A (i, m, and 
o) and either pDes (/') or sm-1 (n and p) show the absence of smoothelin in heart muscle, skeletal muscle, and myoepithelial cells as well 
as in vena (asterisk). Smoothelin is clearly present in smooth muscle cells of arterial vessels (k-m). Bars:  (a, b, c,f, and h) 20 p,m; (d, e, k, 
and/) 10 ~m; (m and n) 6 p~m;  (g, i, and]) 5 I~m;  (o andp) 4 p,m. 
The Journal  of Cell Biology.  Volume 134, 1996  406 nodules,  several epithelia,  neural  and  connective tissues, 
were negative with R4A (Fig. 5). Analysis of different spe- 
cies  evolutionary  as  distant  as  the  teleost  Oreochromis 
mossambicus  and human showed that R4A reacted with 
smooth muscle cells of these species, but no reaction was 
found with mouse, hamster, and rat smooth muscle cells. 
In smooth muscle tissue explants of uterine myoma, the 
smoothelin  mRNA  concentration  dropped  sharply  after 
transfer of tissue into culture medium. Smoothelin mRNA 
was no longer detectable by Northern blotting 12 h  after 
removal of the tissue from the patients (Fig. 6). However, 
immunohistochemical and Western blot analysis of these 
tissue explants revealed that smoothelin protein remained 
present in the tissue up to 5 d after explantation (data not 
shown). The reduction in smoothelin mRNA and protein 
cannot be attributed to degradation or necrosis of the tis- 
sue since GAPDH mRNA and proteins such as vimentin, 
desmin, and a-smooth muscle actin did not diminish.  No 
smoothelin  mRNA  could  be  detected  in  (primary)  cul- 
tures of cells derived from smooth muscle tissue (human 
myoma, human colon, and bovine aorta) or in long-term 
cultured human vascular smooth muscle cells. 
SubceUular Localization and Organization 
of  Smoothelin 
After  homogenization  and  differential  centrifugation 
smoothelin immunoreactivity was found in the 1,000 g and 
Triton X-100 pellet, the same fraction in which cytoskele- 
tal proteins such as desmin and actin were found. Immu- 
nohistochemical  analysis  of  several  tissues  revealed  that 
smoothelin  was  abundantly  present  throughout  smooth 
muscle tissues, but close observation of individual cells in- 
dicated an uneven distribution over the cytoplasm. Confo- 
cal laser scanning microscopy (CSLM) of tissue sections of 
arteries, myoma, and colon as well as primary embryonic 
chicken  gizzard  cells  with  doubled  staining  for  either 
smoothelin/desmin  or smoothelin/a-smooth muscle actin, 
indicated that smoothelin appeared to be organized in or 
be part of a filamentous structure (Fig. 7). From the super- 
Figure 6.  Northern blot of RNAs extracted from human myoma 
explants kept in a culture medium for 0, 4, 8, 12, 24, and 48 h. Hy- 
bridization  with  smoothelin (upper panel) and GAPDH (lower 
panel) cDNAs  shows  that  smoothelin  mRNA  disappears  be- 
tween 8 and 12 h after removal of the tissue from its natural envi- 
ronment. Hybridization with GAPDH cDNA demonstrates that 
this is not due to RNA degradation. 
posed pictures it was obvious that desmin and smoothelin 
showed no colocalization in  both human smooth muscle 
tissues or chicken primary cells (Fig. 7, b and d). Also, lit- 
tle  or  no  colocalization  has  been  observed  between 
smoothelin and a-smooth muscle actin in tissues (Fig. 7 a). 
However, smoothelin colocalized with the stress fibers of 
the primary embryonic chicken cells (Fig. 7 c). 
Since synthesis of smoothelin ceased in smooth muscle 
cell lines and in primary cultures of smooth muscle cells, 
transfection experiments were set up to reveal the cellular 
organization of smoothelin. Transfection of the smoothe- 
lin  cDNA  driven  by a  CMV promotor  (pcDNA3-SMO) 
into human primary smooth muscle cells revealed a  low 
level of smoothelin synthesis and  a  staining pattern  that 
contained both filamentous and stress fiber-like elements 
(Fig. 8 e). However, the numbers of transfected cells were 
low and the filamentous pattern is difficult to see because 
of the  small size of these  cells.  Transfection of the  con- 
struct into rat heart-derived myoblasts resulted within 24 h 
in an abundant expression of smoothelin. Smoothelin ap- 
peared  strongly  associated  with  stress  fibers  (Fig.  8  d). 
However, a  relatively weak filamentous pattern was ob- 
served in addition to the much stronger stained stress fi- 
bers.  A  clearly filamentous pattern was observed in trans- 
fected COS7 cells, 24 h  after transfection. In ~5%  of the 
cells,  extensive filamentous  networks  reactive with R4A 
were found (Fig. 8 a). Observation of the cells after longer 
periods of transient  smoothelin expression showed accu- 
mulation  of R4A  immunoreactive  material  in  the  cyto- 
plasm, but no obvious changes in morphology of the cells 
were  seen.  Double-immunostaining  of  the  transfected 
COS7  cells  showed  that  smoothelin  does  not  colocalize 
with vimentin (Fig. 8, b and c) or keratin intermediate fila- 
ments nor with F-actin. Networks formed by tubulin  and 
smoothelin differed considerably, which was most obvious 
for mitotic cells containing spindles. These results do not 
elucidate to what extent differences in smoothelin patterns 
can be retraced to overproduction due to the  CMV pro- 
motor or to intrinsic differences among the cell lines. As 
mentioned  above,  Western  blotting  of  pcDNA3-SMO- 
transfected cells showed the synthesis of a 59-kD protein, 
reactive with  R4A  (Fig.  3).  In cells transfected with  the 
pcDNA3 plasmid, no R4A reactive material was found in 
immunohistochemical and Western blot assays. 
Discussion 
Although  smooth muscle and striated muscle cells share 
some  structural  proteins,  such  as  desmin,  or  synthesize 
closely related isoforms of proteins, as for actin and myo- 
sin, large differences have been demonstrated in the con- 
struction  and  physiology  of  their  contractile  apparatus. 
For example, structural proteins such as titin and nebulin, 
that are part of the contractile apparatus in striated muscle 
cells, are not found in smooth muscle cells, nor have struc- 
turally comparable molecules been identified as yet. How- 
ever, a  number of smooth muscle-specific proteins, such 
as calponin,  SM-22,  h-caldesmon, and metavinculin have 
been identified and characterized (Lees-Miller et al., 1987; 
Takahashi et al., 1988; Nagai et al., 1989; Frid et al., 1992; 
Owens,  1995).  Several  of  these  smooth  muscle-specific 
proteins are associated with actin and myosin, i.e., the con- 
van der Loop et al. A Smooth Muscle Cell Specific Cytoskeletal  Protein  407 Figure  7.  Confocal  laser 
scanning microscopy  of dou- 
ble-stained  sections  of  hu- 
man artery (a and b) and pri- 
mary  embryonic  chicken 
gizzard cells (c and d). Cells 
and  tissues  were  immu- 
nostained  for  smoothelin 
(red)  and  ct-smooth  muscle 
aetin  (a and e) or desmin  (b 
and  d)  (green). In  a-c, the 
position  of the nucleus is in- 
dicated  by  blue  staining 
(DAPI). 
tractile apparatus, but so far no structural proteins exclu- 
sively expressed in smooth muscle cells have been identi- 
fied. A novel, smooth muscle-specific protein is presented 
which exhibits a filamentous organization and appears to 
be expressed in contractile type cells only. The protein has 
been designated smoothelin. 
Characterization of Smoothelin 
The  nucleic  acid  and  protein  sequences  of  smoothelin 
have been  elucidated  and  its  secondary structure  is pre- 
dicted by computer analysis. The molecular weight as esti- 
mated from the cDNA open reading frame is 40 kD which 
is ~20 kD smaller than the size of the protein as detected 
by Western blotting after SDS-PAGE (Fig. 3). If the full- 
size,  1,593  bases, cDNA is ligated into  a  prokaryotic ex- 
pression vector and translated in bacteria an ~60-kD pro- 
tein is found on SDS-PAGE gels, which is ~10 kD larger 
than  the  calculated molecular weight (~50 kD). This in- 
crease of ~10 kD in apparent molecular weight is proba- 
bly accounted for by a decreased SDS-binding capacity be- 
cause of conformational properties of the alanine-proline 
sequences and the rigidity of the proline-rich region (Ber- 
bers et al.,  1983;  Vaughan  et al.,  1993).  Posttranslational 
additions have to account for the other 10-kD increase of 
molecular weight found in eukaryotic cells. The presence 
of two asparagine-linked N-glycosylation sites and the re- 
sult of the neuramidase treatment are in agreement with 
this explanation. 
Computer-assisted  structure  analysis  of  the  putative 
amino acid sequence revealed potential helical structures 
but they are relatively small compared to those found in 
intermediate filament proteins such as desmin and vimen- 
tin  (Quax-Jeuken  et  al.,  1983).  The  proline  residues  are 
found on both sides of the first helical structure and show 
a major concentration in a proline-rich region in the center 
of the protein. This proline-rich region is located between 
the second potential helical domain of smoothelin and the 
region homologous to the spectrin family (see below). The 
helical domains may be involved in formation of filamen- 
tous structures by coiled-coil interaction  as described for 
intermediate  filament proteins.  The  observations  on  the 
primary embryonic  chicken  gizzard  cells  indicate  a  fila- 
mentous  structure  for  smoothelin.  Also,  transfection  of 
smoothelin cDNA results in the formation of filaments in 
COS7  cells  and  to  a  lesser  extent  in  human  primary 
smooth muscle cells. This is in agreement with the results 
of the CSLM and the fractionation studies of smooth mus- 
cle tissues, suggesting that smoothelin is part of a filamen- 
tous  cytoskeletal/structural  network.  Nevertheless,  there 
still is a possibility that the structures observed are the re- 
sult of association of smoothelin with existing cytoskeletal 
or  membrane-associated structures.  Double  staining  im- 
munofluorescence  assays in  transfected  COS7  cells  indi- 
cated that colocalization with intermediate filaments formed 
by desmin, keratin, and vimentin or with microtubules could 
be excluded,  since staining patterns are largely different. 
Interaction of smoothelin with microfilaments needs fur- 
ther  examination  because  of their  colocalization  in  pri- 
mary embryonic chicken cells and myoblast, and the pres- 
ence of a potential actin-binding site in the protein sequence 
(see below). The results of these experiments should be in- 
terpreted with caution since (a) in the primary chicken giz- 
zard cells the stress fibers are considered to be a culturing 
artifact, and (b) in the transfected cells the CMV promoter 
driven expression may result in such high cellular concen- 
The Journal of Cell Biology, Volume 134,  1996  408 Figure 8.  Immunofluorescence micrographs of COS7 cells transfected  with the full-size human smoothelin cDNA. Transfected cells 
clearly show filamentous structures  reactive with anti-smoothelin R4A (a). Double immunofluorescence staining of COS7 cells with 
R4A (b) and anti-vimentin (pVim) (c). Transfection of the smoothelin cDNA into rat heart-derived myoblasts showed colocalization 
with stress fibers (d) whereas transfection of rat smooth muscle cells showed a colocalization with stress fibers as well as filament for- 
mation (e). Bars: (a) 1 l~m; (b and c) 3 txm; (d and e) 4 ~m. 
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which will not occur under physiological conditions. 
Southern blotting  and  in  situ  hybridization (data  not 
shown) indicate that no sequences with major homologies 
to the  smoothelin cDNA  are  present in the  human  ge- 
nome. However, a 56--amino acid sequence near the car- 
boxy terminal domain of smoothelin shows homology with 
dystrophin, utrophin,  [3-spectrin, and et-actinin.  In these 
members of the spectrin family this sequence is part of the 
amino-terminal  domain,  that  has  been  demonstrated  to 
bind to actin filaments (Winkelman et al., 1990; Baron et al., 
1987;  Dhermy, 1991;  Winder et al.,  1995). According to 
Karinch and coworkers (1990) a highly homologous 140o 
amino acid/16.5-kD fragment of this domain contains the 
actual-binding site(s)  for actin.  Other investigators have 
appointed  three  short  sequences  within  this  140-amino 
acid sequence as being involved in actin binding (Winder 
et al., 1995). However, among the members of the spectrin 
family the homology extends further towards the carboxy 
terminal  for  at  least  another  80-amino  acid  residues 
(Koening et al., 1988; Winkelman et al., 1990; Beggs et al., 
1992; Tinsley et al., 1992). Smoothelin has a 56-amino acid 
sequence  homology within  this  800amino  acid  domain 
(Fig. 2 B). Taking into account the uncertainty of the ac- 
tual sequences involved in actin binding by members of 
the  spectrin family (Winder  et  al.,  1995),  the  56-amino 
acid sequence of smoothelin may possibly function as a 
(truncated)  actin-binding  domain.  The  association  with 
stress fibers in the embryonic chicken gizzard cells, in the 
transfected heart-derived myoblasts and  (to a  lesser ex- 
tend) in human primary smooth muscle cells appears to 
support  the  concept  of  an  extended  actin-binding  se- 
quence. 
Expression of Smoothelin 
Smoothelin is only expressed in fully differentiated smooth 
muscle cells. Expression has been found in smooth muscle 
tissue  of all vertebrate species investigated.  The appar- 
ently high level of evolutionary conservation indicates that 
smoothelin is an important constituent of smooth muscle 
cells. In addition, its expression appears to be more strin- 
gently regulated  as  compared  to  other smooth  muscle- 
specific proteins. Smooth muscle cell components such as 
metavinculin, calponin, smooth muscle a-actin, and smooth 
muscle myosin isoforrns have been observed in nonsmooth 
muscle cells in embryos, in culture, and in pathologically 
affected striated muscle tissue (Babai et al., 1990; McHugh 
et al.,  1991, Ausma et al., 1995).  Also, most of these pro- 
teins  have been found in proliferative stages  of smooth 
muscle cells, whereas smoothelin has been detected only 
in fully differentiated cells. Preliminary results in chicken 
embryos show that smoothelin appears relatively late dur- 
ing  embryogenesis  (around  Hamburger/Hamilton  stage 
36) and has only been observed in smooth muscle tissue. 
Several authors have suggested that smooth muscle cells 
can be divided into two phenotypes: the contractile and 
the proliferating/synthetic smooth muscle cell type (Camp- 
bell and Chamley-Campbell, 1981; Campbell et al., 1989). 
Phenotype switches between these stages  of differentia- 
tion have been suggested, but variation amongst smooth 
muscle cells derived from different organs and the lack of 
reliable differentiation markers have hampered investiga- 
tions  in  this  matter.  Cultured  smooth  muscle  cells  and 
smooth muscle cell lines belong by definition to the prolif- 
erating phenotype. Our results showed that smoothelin is 
not expressed in cultured smooth muscle cells. The embry- 
onic chicken gizzard cells are the exception but they ex- 
press smoothelin only during a limited period of time after 
dispersion  of the  tissue.  The outcome from the  experi- 
ments with the myoma explants too shows a shut-down of 
smoothelin transcription as soon as tissue integrity is dis- 
turbed. The rapid drop in smoothelin mRNA concentra- 
tion  after  explantation  indicates  that  expression  of the 
smoothelin gene depends on factors, autocrine or blood- 
borne, or on continued (neural) stimulation.  Smoothelin 
filaments can be detected 4 or 5 d after explantation, indi- 
cating a  rather slow turnover of the protein once it has 
been  incorporated  into  a  filamentous  structure.  Break- 
down of smoothelin appears to be faster in primary cell 
culture. The results of our observations suggest a relation 
between smoothelin expression and contractile potential. 
Screening of blood vessels of different size and structure 
indicates that smoothelin is only found in vessels with con- 
tractile properties (Van der Loop, 1996). Thus, different 
from other smooth muscle-specific proteins which appear 
to  be  expressed  in  both  proliferative  and  contractile 
smooth muscle cells, smoothelin appears to be specific for 
contractile cells and may be a marker for this stage of dif- 
ferentiation. 
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